Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141715 |
| CAS No | NA |
| Mol.F. | C9H10N6O3 |
| Mol.Wt. | 250.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141716 |
| CAS No | NA |
| Mol.F. | C8H9N3O5 |
| Mol.Wt. | 227.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141717 |
| CAS No | NA |
| Mol.F. | C20H20N2O3 |
| Mol.Wt. | 336.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141718 |
| CAS No | NA |
| Mol.F. | C20H20N2O4 |
| Mol.Wt. | 352.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141719 |
| CAS No | NA |
| Mol.F. | C20H20N2O5 |
| Mol.Wt. | 368.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141720 |
| CAS No | NA |
| Mol.F. | C29H52N2O6 |
| Mol.Wt. | 524.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141721 |
| CAS No | NA |
| Mol.F. | C18H22N2O2 |
| Mol.Wt. | 298.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141722 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141723 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141724 |
| CAS No | NA |
| Mol.F. | C13H8N2O2S |
| Mol.Wt. | 256.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141725 |
| CAS No | NA |
| Mol.F. | C23H25N3O6 |
| Mol.Wt. | 439.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141726 |
| CAS No | 35784-01-1 |
| Mol.F. | C6H10N2O2 |
| Mol.Wt. | 142.16 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141727 |
| CAS No | NA |
| Mol.F. | C16H21N3O4 |
| Mol.Wt. | 319.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141728 |
| CAS No | NA |
| Mol.F. | C22H26N6O5 |
| Mol.Wt. | 454.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141729 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141730 |
| CAS No | NA |
| Mol.F. | C15H24N4O3 |
| Mol.Wt. | 308.4 |
| INV STATUS | CUSTOM SYNTHESIS |